A national study led by UBC researchers at the Centre for Cardiovascular Innovation is shedding light on how to more effectively treat atrial fibrillation (AF) – a common heart rhythm problem associated with increased risk of stroke and heart failure.
Researchers at the University of Maryland School of Medicine’s (UMSOM) Center for Precision Disease Modeling identified how a specific protein in SARS-CoV-2, the virus responsible for COVID-19, damages heart tissue. They then used a drug to reverse the toxic effects of that protein on the heart.
estoring blood flow to the legs, whether through bypass surgery or a less invasive artery-opening procedure with a stent, reduced pain and improved quality of life for people with peripheral artery disease (PAD), according to preliminary, late-breaking research presented today at the American Heart Association’s Scientific Sessions 2022.
مدينة روتشستر، ولاية مينيسوتا — في دراسة جديدة من دراسات الروابط على نطاق الجينوم الخاصة بأمراض الشريان التاجي للمقيمين في قطر، لقد ألقى الباحثون الضوء على البنية الجينية للمرض في مجموعة سكانية محددة.
Lipoprotein(a) is a special type of bad cholesterol that is believed to contribute to heart disease, but there are no approved pharmacological therapies to decrease its concentration in the bloodstream.
Biases in heart disease and metabolic disorder—also known as cardiometabolic—studies are putting the lives of midlife Black and Hispanic women in jeopardy.
A study comparing two approaches for diagnosing heart disease found that a risk analysis strategy is superior to the usual approach of immediately performing functional tests or catheterization for low- to intermediate-risk patients with new-onset chest pain.
For more than four decades, doctors have been split on whether giving steroids during a pediatric open-heart surgery could be helpful for post-operative recovery. A new study is providing a bit more clarity, suggesting there are some benefits for certain kinds of patients.
In a head-to-head comparison of two so-called ‘water pills’ that keep fluid from building up in patients with heart failure, the therapies proved nearly identical in reducing deaths, according to a large study led by Duke Health researchers.
Team members facilitated FaceTime calls and provided comfort care for Nazli Ozkilic’s father, who was in long-term care due to congestive heart failure
مدينة روتشستر، ولاية مينيسوتا -- تزداد مخاطر الإصابة بالخرف والسرطان وأمراض الأوعية الدموية مع التقدم في العمر، وكذا يزداد عدد سكان الولايات المتحدة من كبار السن. لكن العلاقة بين تلك الحالات المرضية ما تزال غير مفهومة بالكامل. في الآونة الأخيرة، أعلن باحثو مايو كلينك عن اكتشاف مثير للاهتمام مفاده: أن وجود تاريخ من الإصابة بالسرطان أو مرض الشريان التاجي قد يقلل من خطر الإصابة بالخرف. ونُشرت نتائج دراستهم في مجلة مرض الزهايمر.
Os riscos de demência, câncer e doença arterial coronariana aumentam com o avanço da idade, e a população dos Estados Unidos está envelhecendo. Mas, até então, a conexão entre as condições não estava plenamente compreendida. Agora, os pesquisadores da Mayo Clinic relatam uma descoberta intrigante: ter histórico de câncer ou doença arterial coronariana pode reduzir o risco de demência. Os resultados do estudo foram publicados na revista médica Journal of Alzheimer's Disease.
Los riesgos de padecer demencia, cáncer y enfermedades vasculares aumentan con la edad, y la población de los EE. UU. está envejeciendo. Sin embargo, no se comprende plenamente la conexión entre las afecciones. Ahora, los investigadores de Mayo Clinic informan un hallazgo interesante: tener antecedentes de cáncer o enfermedad de las arterias coronarias puede reducir el riesgo de padecer demencia. Los resultados del estudio están publicados en la revista Journal of Alzheimer's Disease.
It was the information she couldn’t find that led Amy Kirkham, an assistant professor in the University of Toronto’s Faculty of Kinesiology & Physical Education (KPE), to her latest discovery.
For the first time in Illinois, surgeons at Northwestern Medicine’s Bluhm Cardiovascular Institute successfully transplanted a heart donated after circulatory death (DCD).
Adults with hypertension saw a small, but consequential, rise in their blood pressure levels during the first eight months of the COVID-19 pandemic, while the number of times they had their blood pressure measured dropped significantly, according to a study supported by the National Institutes of Health.
Cardiologists, cardiothoracic surgeons and interventionalists from the Smidt Heart Institute at Cedars-Sinai are presenting an array of innovative research data and leading discussions on medical breakthroughs during the American Heart Association (AHA) Scientific Sessions, taking place in Chicago, Nov. 5-7.
A comprehensive review and meta-analysis of published research confirm that young adults (40 years old and younger) have a slightly elevated risk for myocarditis or pericarditis after mRNA COVID-19 vaccination.
Hypertension control and management worsened during the early months of the COVID-19 pandemic, according to a new analysis conducted at three large health systems, led by Cedars-Sinai investigators.
Artificial intelligence can improve diagnosis and treatment for patients, but first the AI-enabled clinical tools have to be easily available and used.
The destruction of red blood cells, or mechanical hemolysis, is an inevitable complication of interventional devices, so scientists want to gain a better understanding of the phenomenon. In Physics of Fluids, researchers develop a red blood cell destruction model based on simulations of dissipative particle dynamics within a high shear flow. The team discovered that acceleration during shearing is a major factor in red blood cell destruction, beyond exposure time and shear stress. They recommend adding a flow buffer structure to the structural design of ventricular assist devices to reduce part of the hemolysis caused by shear acceleration.
U.S. deaths from heart disease spiked in 2020 at the start of the COVID-19 pandemic after a steady decline from 2010 to 2019, reversing a public health success, according to preliminary research to be presented at the American Heart Association’s Scientific Sessions 2022.
Two minute bursts of vigorous activity totalling 15 minutes a week are associated with a reduced risk of death, according to research published today in European Heart Journal, a journal of the European Society of Cardiology (ESC).1
Several recent discoveries show that the accuracy of diagnosing coronary artery disease and predicting patient risk is improved with the help of artificial intelligence (AI) models developed by scientists in the Division of Artificial Intelligence in Medicine at Cedars-Sinai.
In acknowledgment of her research advancing the field of cardiovascular science, UTHealth Houston’s Louise McCullough, MD, PhD, has been honored with the 2022 American Heart Association Basic Research Prize.
Elite young athletes are set to benefit from a novel screening tool with the potential to change clinical practice by ruling out a serious heart condition frequently misdiagnosed.
Thousands of people have new hope for treatment of thoracic aortic arch disease and UH Harrington Heart & Vascular Institute is at the forefront of studying the safety and efficacy of this new procedure.
Chronic heart failure causes the cell’s powerhouses to dysfunction, in part due to overconsumption of an important intermediary compound in energy production.
New data analysis from the Smidt Heart Institute at Cedars-Sinai found that deaths from heart attacks rose significantly during pandemic surges, including the COVID-19 Omicron surges, overall reversing a heart-healthier pre-pandemic trend.
The Smidt Heart Institute at Cedars-Sinai has selected leading vascular surgeon Donald Baril, MD, as director of the Vascular Surgery Fellowship Program. Baril, who joined Cedars-Sinai in 2020, aims to advance the academic medical center’s excellence in vascular care, research and education for current and future fellows.
Quando falamos em AVCs, cada segundo é importante. Especialistas da Mayo Clinic explicam como reconhecer os sinais de um AVC e como reduzir o seu risco. “Dizemos com frequência que o ‘tempo é valioso para o cérebro,’ o que significa que, quanto mais rápido for restabelecido o fluxo sanguíneo para ele, melhores serão os resultados para o paciente,” afirma o Dr. James Meschia, neurologista da Mayo Clinic, na Flórida.
مدينة روتشستر، ولاية مينيسوتا. — كل ثانية مهمة عند الحديث عن السكتات الدماغية. حيث يشرح أحد خبراء مايو كلينك كيفية التعرف على مؤشرات السَّكتة الدماغية وكيفية التقليل من مخاطر حدوثها.
"نحن نقول دائمًا إن (الوقت من ذهب)، أي أنه كلما أسرعنا في استعادة تدفق الدم إلى الدماغ، صارت النتائج أفضل بالنسبة للمريض" - كما يقول جيمس ميسكيا، دكتور الطب، طبيب الأعصاب في مايو كلينك في فلوريدا.
Cuando se trata de accidentes cerebrovasculares , cada segundo cuenta. Los expertos de Mayo Clinic explican cómo reconocer los signos de un accidente cerebrovascular y cómo reducir el riesgo de que se produzcan. "A menudo decimos 'el tiempo es cerebro' para referirnos a que cuanto antes podamos restaurar el flujo de sangre al cerebro, mejores serán los resultados para el paciente," dice el Dr. James Meschia, neurólogo de Mayo Clinic en Florida .
Physician scientists from the Department of Radiation Oncology at Cedars-Sinai Cancer will present research and discuss advances in clinical care at the American Society for Radiation Oncology (ASTRO) annual meeting Oct. 23-26 in San Antonio.
Researchers at Columbia University Mailman School of Public Health evaluated an expanded measure of cardiovascular health (CVH) that includes sleep as an eighth metric, in relation to cardiovascular disease risk.
For decades, scientists in Berlin have been researching a strange hereditary condition that results in half the members of certain families having unusually short fingers and extremely high blood pressure.
A team at Children’s Hospital Los Angeles recently became the first in the world to use a novel, basket-shaped retrieval device to successfully remove a large right atrial thrombus (blood clot).
After 11 years spent in medical school, residency and fellowships, Elizabeth Chou, MD, a vascular surgeon who recently joined the Smidt Heart Institute at Cedars-Sinai, has earned her dream career. And she has no plans of stopping there. She’s on a path toward ensuring women in vascular surgery are represented—as incoming physicians and as patients.
Vasa Therapeutics, Inc., a preclinical stage company developing first-in-class treatments for cardiovascular indications with limited or no available therapies, today announced two upcoming poster presentations showing data on the company's lead clinical candidate, VS-041, a selective matrix metalloprotease (MMP) inhibitor for treatment of heart failure with preserved ejection fraction (HFpEF) and the discovery of novel calcium/calmodulin-dependent protein kinase II delta (CaMKIIδ) inhibitors for treatment of β-blocker resistant arrythmias, at the American Heart Association (AHA) Scientific Sessions November 5 – 7 in Chicago, IL.
The new study showed apixaban is superior to rivaroxaban against stroke or systemic embolism in patients with atrial fibrillation and valvular heart disease
Currently, the U.S. leads western nations in infant mortality and cardiac birth defects are a leading cause. New research harnesses the power of AI to detect dangerous cardiac abnormalities prenatally. Resulting medical protocols implemented at birth in those at-risk could go a long way toward saving lives.